New Diabetes Drug Poses Major Risks, Panel Says

Review Finds FDA Overlooked Data on Life-Threatening Cardiovascular Effects of Pargluva...

It looks as though one of the drug company's is suffering from a major blow. They have a promising drug but the side effects are, or could kill the type II patient. It seems as though they want to stop a major catastrophe before it could happen. But its a shame that the diabetic could loose a promising drug due to side effects. You can't complain though about the thought of this drug being pulled. It's better for the drug to be pulled than have a major out break of Cardiovascular problems among the diabetic community. So for once they are putting saftey first instead of potential money they could earn. The FDA should of asked for additinal time to Bristol-Myers to do a study on just the cardiovascular problem issue though.

I believe the FDA is falling short when it comes to safety on the drugs they approve. They better watch it because if they keep messing up like this they may find all their jobs replaced with competent workers. Seems like there is a lot of screwups. I admit you can't blame this all on the FDA the drug companies have to take some of the responsibility too. But I just think the FDA is too quick to approve a drug. There must be a certain criteria for them to follow though, and the drug company's must follow it, and maybe even a probation period for the drug, with doctors watching their patient closely. Plus they must stop doctors forcing these new drugs on their patients. It should be volunteer effort. I shouldn't have to go to my doctor fighting to get a older drug that is as good and cheaper. I have had this problem for some time now. I have been refused to change a prescription, take what was offered or nothing at all.

New Diabetes Drug Poses Major Risk